| Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms L Malcovati, E Papaemmanuil, DT Bowen, J Boultwood, MG Della Porta, ... Blood, The Journal of the American Society of Hematology 118 (24), 6239-6246, 2011 | 583 | 2011 |
| Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia L Malcovati, E Papaemmanuil, I Ambaglio, C Elena, A Gallì, ... Blood, The Journal of the American Society of Hematology 124 (9), 1513-1521, 2014 | 281 | 2014 |
| Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma MC Da Vià, O Dietrich, M Truger, P Arampatzi, J Duell, A Heidemeier, ... Nature medicine 27 (4), 616-619, 2021 | 190 | 2021 |
| The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms L Arcaini, S Zibellini, E Boveri, R Riboni, S Rattotti, M Varettoni, ... Blood, The Journal of the American Society of Hematology 119 (1), 188-191, 2012 | 188 | 2012 |
| Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes MG Della Porta, E Travaglino, E Boveri, M Ponzoni, L Malcovati, ... Leukemia 29 (1), 66-75, 2015 | 165 | 2015 |
| Spectrum and functional validation of PSMB5 mutations in multiple myeloma S Barrio, T Stühmer, M Da-Viá, C Barrio-Garcia, N Lehners, A Besse, ... Leukemia 33 (2), 447-456, 2019 | 115 | 2019 |
| Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry L Pagano, M Caira, A Candoni, F Aversa, C Castagnola, C Caramatti, ... Clinical infectious diseases 55 (11), 1515-1521, 2012 | 98 | 2012 |
| Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) M Caira, A Candoni, L Verga, A Busca, M Delia, A Nosari, C Caramatti, ... haematologica 100 (2), 284, 2015 | 96 | 2015 |
| Gene expression comparison between the lymph node-positive and-negative reveals a peculiar immune microenvironment signature and a theranostic role for WNT targeting in … A Argentiero, S De Summa, R Di Fonte, RM Iacobazzi, L Porcelli, ... Cancers 11 (7), 942, 2019 | 79 | 2019 |
| Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1 I Ambaglio, L Malcovati, E Papaemmanuil, CM Laarakkers, ... haematologica 98 (3), 420, 2013 | 61 | 2013 |
| IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma S Barrio, U Munawar, YX Zhu, N Giesen, CX Shi, M Da Viá, R Sanchez, ... Haematologica 105 (5), e237, 2020 | 59 | 2020 |
| High-risk multiple myeloma: integrated clinical and omics approach dissects the neoplastic clone and the tumor microenvironment AG Solimando, MC Da Vià, S Cicco, P Leone, G Di Lernia, D Giannico, ... Journal of clinical medicine 8 (7), 997, 2019 | 59 | 2019 |
| Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression AG Solimando, MC Da Vià, P Leone, P Borrelli, GA Croci, P Tabares, ... haematologica 106 (7), 1943, 2021 | 55 | 2021 |
| CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous … MC Da Vià, AG Solimando, A Garitano‐Trojaola, S Barrio, U Munawar, ... The oncologist 25 (2), 112-118, 2020 | 48 | 2020 |
| Single-and double-hit events in genes encoding immune targets before and after T cell–engaging antibody therapy in MM MS Truger, J Duell, X Zhou, L Heimeshoff, A Ruckdeschel, M John, ... Blood advances 5 (19), 3794-3798, 2021 | 40 | 2021 |
| Comparison of 11C-choline and 11C-methionine PET/CT in multiple myeloma C Lapa, M Kircher, M Da Via, M Schreder, L Rasche, KM Kortüm, ... Clinical nuclear medicine 44 (8), 620-624, 2019 | 40 | 2019 |
| Cereblon enhancer methylation and IMiD resistance in multiple myeloma L Haertle, S Barrio, U Munawar, S Han, X Zhou, C Vogt, RA Fernández, ... Blood, The Journal of the American Society of Hematology 138 (18), 1721-1726, 2021 | 36 | 2021 |
| HB-EGF–EGFR signaling in bone marrow endothelial cells mediates angiogenesis associated with multiple myeloma L Rao, D Giannico, P Leone, AG Solimando, E Maiorano, C Caporusso, ... Cancers 12 (1), 173, 2020 | 36 | 2020 |
| Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes MJ Steinhardt, E Wiercinska, M Pham, GU Grigoleit, A Mazzoni, M Da-Via, ... Journal of Translational Medicine 18, 1-6, 2020 | 27 | 2020 |
| Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel) C Cattaneo, P Zappasodi, V Mancini, C Annaloro, F Pavesi, C Skert, ... Annals of hematology 95, 1955-1963, 2016 | 24 | 2016 |
